Immunology and Inflammatory Biotech Company Bambusa (BBTX.US) Sets IPO Price at $15-$17 Per Share, Plans to Raise $150 Millions
智通财经2026/10/27 07:21Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
According to Golden Ten Data APP, Bambusa Therapeutics, a biotechnology company focusing on immunology and inflammation, announced the terms of its initial public offering (IPO) on Monday. The company plans to raise $150 million by issuing 9.4 million shares at a price range of $15 to $17 per share. Based on the midpoint of the proposed price range, Bambusa Therapeutics’ fully diluted market value will reach $837 million. The company plans to list on Nasdaq under the ticker symbol “BBTX.” The IPO is expected to be priced during the week of October 26, 2026.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Libya's Hamada oil pipeline blocked, losses exceed $30.7 million
智通财经•2026/11/22 01:06


Amazon reportedly to acquire AI startup Decart for $7.5 billion
智通财经•2026/11/21 17:56

Crypto prices
MoreBitcoin
BTC
$60,070.22
+1.69%
Ethereum
ETH
$1,682.33
+3.60%
Tether USDt
USDT
$0.9979
+0.00%
BNB
BNB
$549.67
+1.95%
USDC
USDC
$0.9999
-0.00%
XRP
XRP
$0.9305
+2.43%
Solana
SOL
$70.29
+1.97%
TRON
TRX
$0.3050
+1.32%
Hyperliquid
HYPE
$61.4
+1.12%
Zcash
ZEC
$780.2
+3.37%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now